Top

Published in:

01-09-2019 | Amphotericin B | Case report

Cytarabine/daunorubicin

Ecthyma gangernusom secondary to Escherichia coli bacteraemia: case report

Published in: Reactions Weekly | Issue 1/2019

Excerpt

A 45-year-old woman developed ecthyma gangernusom secondary to Escherichia coli bacteraemia following treatment with cytarabine and daunorubicin for acute myeloid leukaemia. …

Salehi M, et al. Ecthyma gangrenosum due to escherichia coli bacteremia in a patient with acute myeloid leukemia: A case report and a literature review about E. coli-induced Ecthyma gangrenosum. Iranian Journal of Clinical Infectious Diseases 14: No. 3, Jun 2019. Available from: URL: http://doi.org/10.5812/archcid.66413 -Iran

Title: Cytarabine/daunorubicin
Ecthyma gangernusom secondary to Escherichia coli bacteraemia: case report
Publication date: 01-09-2019
Publisher: Springer International Publishing
Keywords: Amphotericin B
Acute Myeloid Leukemia
Escherichia Coli
Aplastic Anemia
Imipenem
Amikacin
Vancomycin
Cytostatic Therapy
Published in: Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-67163-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cytarabine/daunorubicin

Ecthyma gangernusom secondary to Escherichia coli bacteraemia: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

Bupivacaine

Alprazolam/buprenorphine/oxycodone

Gefitinib

Opioid maintenance treatment: neonatal outcomes not worsened

Mycophenolate mofetil/prednisone/tacrolimus

Temozolomide